Effects of the lipase inhibitor orlistat on intake and preference for dietary fat in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Ackroff, Karen ^a   Sclafani, Anthony ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

carbohydrate intake; conditioned flavor aversions preferences; macronutrient self selection; protein intake

Indexed keywords

TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FAT INTAKE; FEMALE; LIPID ABSORPTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; RAT;

EID: 33745346198     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.1.r48     Document Type: Article

References (18)

1. Ackroff, K., and A. Sclafani. Sucrose-induced hyperphagia and obesity in rats fed a macronutrient self-selection diet. Physiol. Behav. 44: 181-187, 1988.
2. Castonguay, T. W., S. L. Burdick, M. A. Guzman, G. H. Collier, and J. S. Stern. Self-selection and the obese Zucker rat: the effect of dietary fat dilution. Physiol. Behav. 33: 119-126, 1984.
3. Drent, M. L., I. Larsson, T. William-Olsson, F. Quaade, F. Czubayko, K. von Bergmann, W. Strobel, L. Sjöström, and E. A. van der Veen. Orlistat (RO 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int. J. Obes. 19: 221-226, 1995.
4. Drent, M. L., and E. A. van der Veen. Lipase inhibition: a novel concept in the treatment of obesity. Int. J. Obes. 17: 241-244, 1993.
5. Drewnowski, A. The new fat replacements: a strategy for reducing fat consumption. Postgrad. Med. 87: 111-121, 1990.
6. Elizalde, G., and A. Sclafani. Fat appetite in rats: flavor preferences conditioned by nutritive and non-nutritive oil emulsions. Appetite 15: 189-197, 1990.
7. Güzelham, C., J. Odink, J. J. N. Jansen-Zuidema, and D. Hartmann. Influence of dietary composition on the inhibition of fat absorption by orlistat. J. Int. Med. Res. 22: 255-265, 1994.
8. Hadvary, P., H. Lengsfeld, A. Fleury, E. Hochuli, E. Kupfer, J. M. Meier, F. Schneider, E. Weibel, and U. Widmer. Lipstatin and tetrahydrolipstatin, potent and selective inhibitors of pancreatic lipase (Abstract). Int. J. Obes. 11, Suppl. 2: 21, 1987.
9. Hogan, S., A. Fleury, P. Hadvary, H. Lengsfeld, M. K. Meier, J. Triscari, and A. C. Sullivan. Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int. J. Obes. 11, Suppl. 3: 35-42, 1987.
10. Isler, D., C. Moeglen, N. Gains, and M. K. Meier. Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-δ-linolenin and tripalmitin in mice. Br. J. Nutr. 73: 851-862, 1995.
11. Johnson, S. L., L. McPhee, and L. L. Birch. Conditioned preferences for flavors associated with high dietary fat. Physiol. Behav. 50: 1245-1251, 1991.
12. Lucas, F., and A. Sclafani. Flavor preferences conditioned by intragastric fat infusions in rats. Physiol. Behav. 46: 403-412, 1989.
13. National Research Council. Diet and Health. Washington, DC: Natl. Acad. Press, 1989.
14. Sclafani, A. Dietary obesity. In: Obesity, edited by A. J. Stunkard. Philadelphia, PA: Saunders, 1980, p. 166-181.
15. Sclafani, A., and P. F. Aravich. Macronutrient self-selection in three forms of hypothalamic obesity. Am. J. Physiol. 244 (Regulatory Integrative Comp. Physiol. 13): R686-R694, 1983.
16. Sclafani, A., H. S. Koopmans, J. R. Vasselli, and M. Reichman. Effects of intestinal bypass surgery on appetite, food intake, and body weight in obese and lean rats. Am. J. Physiol. 234 (Endocrinol. Metab. Gastrointest. Physiol. 3): E389-E398, 1978.
17. Tepper, B. J., and R, B. Kanarek. Selection of protein and fat by diabetic rats following separate dilution of the dietary sources. Physiol. Behav. 45: 49-61, 1989.
18. Weibel, E. K., P. Hadvary, E. Hochuli, E. Kupfer, and H. Lengsfeld. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J. Antibiot. Tokyo 40: 1081-1085, 1987.